amoxil tablets
kievmedpreparat pjsc - amoxicillin (amoxicillin trihydrate) - tablets - 500mg
amoxil tablets
kievmedpreparat pjsc - amoxicillin (amoxicillin trihydrate) - tablets - 250mg
cartia
padagis israel agencies ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
iboo 2 % for children
abic marketing ltd, israel - ibuprofen - suspension - ibuprofen 100 mg / 5 ml - ibuprofen - for the reduction of fever and relief of mild to moderate pain.
iodicare solution
vitamed pharmaceutical industries ltd - povidone-iodine - solution - povidone-iodine 10 %w/v - povidone-iodine - antiseptic for treatment of wounds, skin infections in cases of mycosis, trichomonas and infections caused by sensitive microorganisms.
glycerin suppositories rectal
nizhpharm jsc - glycerol - suppositories rectal - 1,24g
streptomycin sulfate powder for solution for i/m injection
"sintez" ojsc - streptomycin (streptomycin sulfate) - powder for solution for i/m injection - 1000mg
sodium bicarbonate solution for infusion
liqvor cjsc - sodium bicarbonate - solution for infusion - 84mg/ml
implicor 50mg/7.5mg tablets film-coated
les laboratoires servier industrie - metoprolol (metoprolol tartrate), ivabradine (ivabradine hydrochloride) - tablets film-coated - 50mg+ 7,5mg
eliquis 2.5 mg
pfizer pharmaceuticals israel ltd - apixaban - film coated tablets - apixaban 2.5 mg - apixaban - apixaban - prevention of venous thromboembolic events (vte) in adult patients who have undergone elective hip or knee replacement surgery.prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (nvaf), with one or more risk factors, such as prior stroke or transient ischaemic attack (tia); age≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (nyha class ≥ ii).treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.